Bioactive compounds in coffee and tobacco may combat Parkinson’s disease

Tobacco and coffee contain bioactive compounds that may reduce Parkinson’s disease risk by targeting key pathways such as MAO B inhibition, α-synuclein aggregation, and neuroinflammation.